Evidence-Based Medicine Guidelines
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aromatase Inhibitors for Treatment of Advanced Breast Cancer in Postmenopausal Women." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456990/all/Aromatase_inhibitors_for_treatment_of_advanced_breast_cancer_in_postmenopausal_women.
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456990/all/Aromatase_inhibitors_for_treatment_of_advanced_breast_cancer_in_postmenopausal_women. Accessed December 3, 2023.
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456990/all/Aromatase_inhibitors_for_treatment_of_advanced_breast_cancer_in_postmenopausal_women
Aromatase Inhibitors for Treatment of Advanced Breast Cancer in Postmenopausal Women [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456990/all/Aromatase_inhibitors_for_treatment_of_advanced_breast_cancer_in_postmenopausal_women.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
ID - 456990
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456990/all/Aromatase_inhibitors_for_treatment_of_advanced_breast_cancer_in_postmenopausal_women
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
